MICHAEL C. DUGAN - 31 Aug 2021 Form 4 Insider Report for BIOCEPT INC

Role
Chief Med Off & Med. Director
Signature
/s/ Michael W. Nall, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
31 Aug 2021
Net transactions value
$0
Form type
4
Filing time
02 Sep 2021, 21:22:45 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Employee Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 31 Aug 2021 Common Stock 150,000 $3.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option shall vest monthly following the Vesting Commencement Date of 8/31/21 until fully vested on 8/31/2024.